Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 31, 2026
July 31, 2026
2c6a5c99-ec56-4af1-a9c3-791ae292275e
Related Documents
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Guidance DocumentMarch 17, 2026Center for Drug Evaluation and Research
Pulmonary Tuberculosis: Developing Drugs for Treatment: Guidance for Industry
Guidance DocumentMay 8, 2026Center for Drug Evaluation and Research
Certain Postapproval Requirements and Resources for ANDAs
Guidance DocumentJune 4, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.